The keynote speakers for the 17th YSA PhD Symposium are announced! 🔬 Muhammad Mohiuddin, University of Maryland School of Medicine 🔬 Florian Krammer, Icahn School of Medicine at Mount Sinai 🔬 Christoph Hitzenberger, #MedUniWien 🔬 Andreas Rowald, FAU Erlangen-Nbg 🔬 Anna Obenauf, IMP Register now! ➡️ bit.ly/3lAAiT2

🧠 #Gehirn im Fokus: Am 01.07. geben Romana Höftberger und Rupert Lanzenberger in ihren Antrittsvorlesungen an der #MedUniWien spannende Einblicke in ihre Fachgebiete. Jetzt anmelden und mehr über #Neuropathologie und #Neurowissenschaften erfahren! ➡️ bit.ly/3Js9Ynx

Amazing Keynote Lecture! Thank you so much for sharing your exciting data and time with us at the MedUni Wien YSA PhD Symposium 2022, Florian Krammer! #research #medicine #youngscientists

New approach to look at sections stained for pathological tau (Alzheimer sample) with microscope. New dimensions.

Tröscher et al. show that in patients with GAD65 antibody-associated temporal lobe epilepsy, cytotoxic T cells attack and kill neurons and are responsible for the early neuronal loss. bit.ly/3hglZUH

🥁PAPER ALERT🥁 🚨 What’s the risk of #seizure relapse after postsurgical antiseizure medication withdrawal? With data from 9 #epilepsy centers, we built models to predict individualized outcomes. Marian Galovic UCL Queen Square Institute of Neurology yesILAE Our findings 🧵 doi.org/10.1093/brain/…

TRAILBLAZER-ALZ 2: Among patients with early symptomatic #AlzheimerDisease and amyloid and tau pathology, donanemab treatment significantly slowed clinical progression at 76 weeks. ja.ma/46VFver #AAIC23